Tumor markers are assuming a growing role in all aspects of cancer care, starting from
screening to follow-up after treatment, and their judicious application in clinical practice …

OBJECTIVES: New biomarkers are being developed to identify individuals at risk for cancer,
detect disease earlier, determine prognosis, detect recurrence, predict response to particular …

A tumor marker is defined as a substance that is produced by the body in response to cancer
or by the cancer tissue itself. Since discovery of the Bence-Jones protein in 1848 and AFP …

Context Advances in molecular biomarkers of the gastrointestinal tract have contributed to a
decline in the incidence of and mortality from diseases of the gastrointestinal tract. The …

Abiomarker as defined by a National Institutes of Health workshop in 2001 is ''a
characteristic that is objectively measured as an indicator of normal biologic or pathologic …

Abstract Background: Updated National Academy of Clinical Biochemistry Laboratory
Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

Colorectal cancer (CRC) is the third leading cause of cancer‐related deaths worldwide. It
has been estimated that more than one‐third of patients are diagnosed when CRC has …

The last 15 years have witnessed dramatic advances in the detection, assessment, and
management of cancer. Progress is due to increased knowledge of the basic biology of …

Modern pharmaceuticals and medical devices have provided substantial benefits to patients
throughout the world. These benefits come at a high and increasing cost, with development …

In spite of advances in diagnostics and therapeutics, cancer remains the second leading
cause of death in the US Successful cancer treatment depends not only on better therapies …